Researchers at The Jackson Laboratory (JAX) may have just cracked one of medicine’s biggest challenges: how to stop influenza ...

Unlike current FDA-approved flu treatments, which target viral enzymes and can quickly become useless as the virus mutates, ...

Researchers hope the antibody cocktail could work as a standalone prophylactic for high-risk groups, in addition to serving as a therapy for those severely ill with flu.

The global mice model market size is calculated at USD 1.73 billion in 2025 and is expected to reach around USD 4.1 billion ...

In a major step toward treating rare neurological diseases, scientists have used gene editing to correct mutations inside the ...

Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...

Scientists have corrected gene mutations in mice causing an ultra-rare disease by editing DNA directly in the brain with a single injection, a feat with profound implications for patients with ...